alprazolam extended release

Generic: alprazolam

Labeler: actavis pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name alprazolam extended release
Generic Name alprazolam
Labeler actavis pharma, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

alprazolam 3 mg/1

Manufacturer
Actavis Pharma, Inc.

Identifiers & Regulatory

Product NDC 0228-3086
Product ID 0228-3086_e89f9f55-9cd1-4b9d-b0a0-2d0480dd559c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078056
DEA Schedule civ
Marketing Start 2007-03-12
Marketing End 2026-07-31

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 02283086
Hyphenated Format 0228-3086

Supplemental Identifiers

RxCUI
433798 433799 433800 433801
UPC
0302283083061
UNII
YU55MQ3IZY
NUI
N0000175694 M0002356

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alprazolam extended release (source: ndc)
Generic Name alprazolam (source: ndc)
Application Number ANDA078056 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 3 mg/1
source: ndc
Packaging
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-3086-06)
source: ndc

Packages (1)

0228-3086-06 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-3086-06)

Ingredients (1)

alprazolam (3 mg/1)

Linked Drug Pages (1)

Alprazolam Extended Release ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e89f9f55-9cd1-4b9d-b0a0-2d0480dd559c", "openfda": {"nui": ["N0000175694", "M0002356"], "upc": ["0302283083061"], "unii": ["YU55MQ3IZY"], "rxcui": ["433798", "433799", "433800", "433801"], "spl_set_id": ["a64496be-bf43-4ba9-a4b1-bd632965c1a0"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-3086-06)", "package_ndc": "0228-3086-06", "marketing_end_date": "20260731", "marketing_start_date": "20070312"}], "brand_name": "Alprazolam Extended Release", "product_id": "0228-3086_e89f9f55-9cd1-4b9d-b0a0-2d0480dd559c", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "0228-3086", "dea_schedule": "CIV", "generic_name": "Alprazolam", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alprazolam", "brand_name_suffix": "Extended Release", "active_ingredients": [{"name": "ALPRAZOLAM", "strength": "3 mg/1"}], "application_number": "ANDA078056", "marketing_category": "ANDA", "marketing_end_date": "20260731", "marketing_start_date": "20070312"}